Stephen Northrup Email & Phone Number

Washington, Dc, Us

Lewisville, Texas , Us

I lead the 10-person government affairs team for the nation’s leading provider of air and ground ambulance services, representing GMR’s interests at the federal, state, and local levels.

I co-founded a bipartisan healthcare lobbying and consulting firm, where we provided comprehensive legislative, regulatory and political strategies on federal and state policy issues to associations, companies, and other organizations in the health care industry.Among our accomplishments:* We helped an industry association defeat burdensome regulations that would have limited consumer access to dietary supplements* We helped an industry association fix a Medicare payment policy that had caused clinical laboratories to be reimbursed for services at below-market rates* We obtained favorable placement on a state pharmacy formulary for a client’s pharmaceutical product, giving their product a marketing advantage over competing products.* We helped a client ensure that a regulatory re-classification of biologics would not delay the FDA’s approval of their application for a generic insulin product.* We helped a non-profit association delay and ultimately defeat a Medicare payment policy that would have limited reimbursement for short but medically necessary hospital inpatient visits. * We secured legislative language for a client that created a specific new class of sunscreen in law to expedite approval of new sunscreen products.* We worked with a House committee to organize a bipartisan health innovation roundtable in Texas hosted by a client, involving multiple Members of Congress and representatives of the local community

Washington, Dc, Us

I was promoted to co-chair the health care practice at one of the largest lobbying firms in Washington, where I generated nearly $1.5 million in additional annual revenues for the firm. The new clients I added to the firm's roster included multiple Fortune 500 biopharmaceutical and health care companies, a small biotech company, and a major chemical industry association.I led projects that ended in successful resolution of issues for clients, from withdrawal of an unworkable proposed regulation for clinical laboratories to resolution of a TRICARE certification dispute for a regional hospital system. I also coordinated a legislative campaign that resulted in a unanimous House vote to approve a change to the Affordable Care Act's individual insurance coverage mandate.I also delivered presentations to Fortune 500 boards of directors, participated in panel discussions at health policy conferences, and organized a roundtable discussion on genomic medicine in London for a client in partnership with the Royal Society of Medicine.

Indianapolis, Indiana, Us

I led the federal affairs team for a Fortune 50 health benefits company (then known as WellPoint) during the debate over the Affordable Care Act.I was responsible for coordinating the company's strategic engagement with Members of Congress and federal agency officials, for engaging with numerous associations and coalitions in Washington, and for directing over $1 million per cycle in political contributions from the company's political action committee.My team collaborated with our CEO, other senior executives, and various industry associations to successfully challenge $50b in proposed cuts to the Medicare Advantage programs, pressing our case directly with dozens of Members of Congress.I prepared witnesses to testify and respond to multiple Congressional oversight committees, acting as primary liaison between corporate counsel and Congressional investigative staff. I also helped the company respond to inquiries from the Centers for Medicare and Medicaid Services and the HHS Inspector General.

Washington, District Of Columbia, Us

I was promoted to serve under then-Chairman Mike Enzi of Wyoming and help the Chairman develop and execute an agenda across public health, food and drug regulation, health insurance, health care quality, and other health policy topics. I represented the Chairman’s interests to Congressional staff, constituents, and special interest groups. I recruited and built a staff of 10 senior-level policy professionals to execute the Committee’s health policy agenda, which resulted in nearly 20 bills signed into law in one Congress across diverse subjects. My team led the investigation of the Vioxx recall and the subsequent legislative negotiations that led to a major bipartisan overhaul of FDA’s approach to drug safety: the Risk Evaluation and Mitigation Strategy (REMS) program. A New England Journal of Medicine article hailed it as “the most important drug-safety legislation in a century," and a 2013 Brookings Institution paper acknowledged that the REMS program has enabled FDA "to facilitate access to a host of drugs that may not have otherwise been approved and allow products to remain on the market with greater confidence."I also led the bipartisan team that drafted and negotiated the Pandemic and All-Hazards Preparedness Act, which created the Office of HHS Assistant Secretary for Preparedness and Response (ASPR) and the Biomedical Advanced Research and Development Authority (BARDA), both of which were central to the nation’s biomedical response to the COVID-19 pandemic.Our team advanced legislation across a variety of issue areas, including HIV/AIDS treatment, patient safety and quality improvement, umbilical cord blood banking, health information technology, radiation therapy and diagnostic imaging standards, genetic information non-discrimination, and tobacco regulation.

Washington, District Of Columbia, Us

I built the policy foundation for Senator Enzi's elevation to serve as committee chairman by developing and amending bills on important policy issues. I contributed ideas and amendments to high-profile legislation that created the Medicare Part D drug benefit and the President’s Emergency Plan for AIDS Relief (PEPFAR), as well as an update to the law governing pharmaceutical patents and generic drug competition (“Hatch-Waxman”). I developed and drafted innovative bipartisan legislation to support state-based alternative approaches to resolving medical malpractice cases.

I helped create and lead an association comprised at the time of the five major national operators of pharmacies that serve nursing homes, assisted-living facilities, and other long-term care sites. I coordinated and directed the association’s federal and state advocacy campaigns, focusing primarily on ensuring adequate reimbursement from state Medicaid programs and the federal Medicare program for the specialized services provided by long-term care pharmacies.In my role, I created critical management and policy-setting systems for the organization, developed state-level chapters comprised of representatives from member companies in more than 20 states, and managed the activities of contract lobbyists in those same states. In doing so, I worked directly with the five member company CEOs and other senior company executives. I also directed the association's political activities, including the development of grassroots networks and coordination of polItical fundraisers.During my tenure, we successfully defeated or mitigated major reimbursement reductions in several states, including a more than $25 million budget victory for the sector in one year in Massachusetts. I coordinated the publication of the first study of the actual costs of drug dispensing in long-term care pharmacies. I developed the organization’s first budget (more than $2 million) and led the initiative to aggregate campaign support from member companies and executives in target states. I also oversaw the development of the organization’s Web site.

Washington, Dc, Us

I led the national association that represents and serves the entrepreneurial sector of the U.S. medical technology industry. As executive director, I served as primary liaison to the legislative and executive branches of the federal government, while managing all aspects of the association’s agenda. Beyond legislative and regulatory affairs, my responsibilities included strategic planning, public relations, membership development, and membership education and services. In the first two years of my tenure, we doubled the association’s revenues. Over my four years at MDMA, we grew the association’s membership from 70 to more than 150 dues-paying members. We successfully developed strategies to build and expand the association’s relationships and influence with Congress, the Food and Drug Administration (FDA) and the Health Care Financing Administration (now CMS). During my tenure, we won legislative and regulatory battles:* against the imposition of medical-device user fees, * for transparency in the Medicare coverage and payment processes,* against the unlawful reprocessing of single-use medical devices by hospitals and third parties,* for the creation of a new FDA office to oversee the review of drug-device combination products, and* against the dominance of the major healthcare group purchasing organizations. I also helped raise the association's profile through national media appearances and through testifying before federal and state agencies and advisory committees. We developed a variety of new programs for association members, including the first series of national industry conferences focused on securing adequate reimbursement for medical technologies. I also supervised Web site and membership database redesign projects.I helped identify and recruit diverse new CEOs for the association’s board of directors, including the first woman and the first person of color to serve on the board.

Maywood, Il, Us

I directed federal and state legislative affairs for a leading academic medical center.In this role, I championed a successful initiative in Washington to defeat a change to Medicare regulations that would have unfairly shifted funding to a competing hospital.In the state capital of Springfield, I led a coalition that secured a new state funding source for medical research at academic medical centers and institutions across Illinois.In my community relations role, I built a successful program to provide vaccinations for indigent children in the area around the medical center.

Washington, Dc, Us

I advocated on a wide variety of health care and higher-education policy issues for the non-profit organization that represents the nation's medical schools and teaching hospitals.

Mpa, Public Administration

Bachelor Of Arts - Ba, Political Science And Government